Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
ID
CAS
209410-46-8
Purity
95%
VX-745 is an ATP-competitive inhibitor of MAPK14. This is a selective probe with some off-target activity against p38β; it is able to cross the blood-brain barrier.
Properties
Name
VX-745
Smiles
FC=1C=CC(SC=2C=CC3=C(C=4C(Cl)=CC=CC4Cl)C(=O)N=CN3N2)=C(F)C1
Targets
Please log in to see this information
Target name
Target pX
Target action
doi
SDS
VX-745 | neflamapimod
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$61
2 mg
$66
5 mg
$71
10 mg
$90
15 mg
$99
20 mg
$107
25 mg
$120
30 mg
$129
35 mg
$138
40 mg
$155
45 mg
$166
50 mg
$180
75 mg
$255
100 mg
$300
Quantity
1
Total amount
$ 71
VX-745 | neflamapimod
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.